Stocks:
5,472
ETFs:
2,400
Exchanges:
11
Market Cap:
$59.01T
24h Vol:
$9.95B
Dominance:
MSFT:5.13%
Stocklytics Platform
BETA
IHE

iShares U.S. Pharmaceuticals ETF

IHE
$207.80arrow_drop_down-0.17%-$0.37

Performance History

Stocklytics logo
Key Stats
Open$207.53
Prev. Close$208.17
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap-
PE Ratio-
LOWHIGH
Day Range207.53
208.13
52 Week Range166.09
208.67
Ratios
P/B Ratio-
Revenue-
Operating M. %-
Earnings-
Earnings Growth %-
EBITDA Margin %-
ROE %-
EPS-

About iShares U.S. Pharmaceuticals ETF (IHE)

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.

Sector
-
Industry
-
CEO
-
Headquarters
-
Employees
0
Exchange
NYSE

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$251.94
24H (%)arrow_drop_up0.27%
24H ($)$0.70
MARKET CAP$522.57B
PRICE$506.92
24H (%)arrow_drop_up0.18%
24H ($)$0.94
MARKET CAP$464.38B
PRICE$509.32
24H (%)arrow_drop_up0.17%
24H ($)$0.89
MARKET CAP$316.00B
PRICE$218.77
24H (%)arrow_drop_up0.83%
24H ($)$1.82
MARKET CAP$192.49B
add iShares U.S. Pharmaceuticals ETF to watchlist

Keep an eye on iShares U.S. Pharmaceuticals ETF

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.